BLUEPRINT MEDICINES CORP shareholders Q2 2024

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 306 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2024. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

BLUEPRINT MEDICINES CORP shareholders Q2 2024
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 114,600$12,351,58811.91%
Rock Springs Capital Management LP 2,460,417$265,183,7447.98%
Ally Bridge Group (NY) LLC 75,638$8,152,2644.86%
Orion Investment Co 108,790$11,725,3864.67%
Integral Health Asset Management, LLC 340,000$36,645,2003.48%
First Turn Management, LLC 184,901$19,928,6303.24%
DAFNA Capital Management LLC 104,763$11,291,3562.70%
Casdin Capital, LLC 326,378$35,177,0212.70%
Avidity Partners Management LP 383,000$41,279,7401.75%
EMERALD MUTUAL FUND ADVISERS TRUST 278,333$29,998,7311.57%
EMERALD ADVISERS, LLC 341,200$36,774,5361.54%
Ghost Tree Capital, LLC 40,000$4,311,2001.35%
Hood River Capital Management LLC 502,820$54,193,9401.12%
Novo Holdings A/S 175,000$18,861,5001.10%
NBW CAPITAL LLC 51,030$5,500,0131.08%
EAM Global Investors LLC 41,242$4,445,0631.00%
Woodline Partners LP 880,147$94,862,2440.90%
O'Neil Global Advisors, Inc. 13,283$1,4320.67%
Redmile Group, LLC 94,405$10,174,9710.62%
Granahan Investment Management 139,732$15,060,3150.60%
External links

This page lists BLUEPRINT MEDICINES CORP's shareholders in Q2 2024. To view BLUEPRINT MEDICINES CORP's shareholder history, click here.